Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29801 | 147 | 25.1 | 26% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
390 | 16316 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COLLABORATIVE DRUG THERAPY | Author keyword | 1 | 50% | 1% | 1 |
2 | FOOD AND NUTRIENT CONSUMPTION | Author keyword | 1 | 50% | 1% | 1 |
3 | OPHTHALMOL NEPHROL | Address | 1 | 50% | 1% | 1 |
4 | PROBABILITY OF BEING IN RESPONSE FUNCTION | Author keyword | 1 | 50% | 1% | 1 |
5 | NUTRIENT CALCULATION | Author keyword | 0 | 33% | 1% | 1 |
6 | RESPONSE AND SURVIVAL | Author keyword | 0 | 33% | 1% | 1 |
7 | TRAINED RUNNERS | Author keyword | 0 | 33% | 1% | 1 |
8 | COLD PRESSURE TEST | Author keyword | 0 | 10% | 1% | 1 |
9 | HLTH SCI AMARILLO | Address | 0 | 10% | 1% | 1 |
10 | ATP III ADULT TREATMENT PANEL III | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY TRIALS | 0 | 17% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM DESIGN, METHODS, AND BASE-LINE CHARACTERISTICS AND BLOOD-PRESSURE RESPONSE OF THE STUDY POPULATION | 1986 | 26 | 4 | 75% |
Methodological problems in evaluating duration of response to therapy in cancer clinical trials | 1997 | 2 | 14 | 29% |
CLINICAL-PATTERN AND DIAGNOSIS OF EARLY SIGNS OF CEREBRAL-CIRCULATION INSUFFICIENCY | 1991 | 0 | 7 | 71% |
MILD HYPERTENSION AS A RISK FACTOR FOR VASCULAR DISEASES OF THE BRAIN | 1988 | 1 | 17 | 29% |
HYPERTENSION IS A MYTH - HIGH(ER) ARTERIAL-PRESSURE IS THE PROBLEM | 1984 | 1 | 3 | 67% |
THE IMPACT OF PREVENTIVE CARDIOLOGY ON CORONARY-ARTERY DISEASE | 1988 | 4 | 31 | 13% |
Hypertension in women | 2004 | 63 | 35 | 3% |
A 10-YEAR PROSPECTIVE-STUDY, 1964-1974, OF CARDIOVASCULAR RISK-FACTORS IN MEN AND WOMEN FROM THE GLOSTRUP POPULATION BORN IN 1914 | 1982 | 24 | 8 | 38% |
HYPERTENSION IS A MYTH | 1983 | 6 | 4 | 25% |
Moderately elevated blood pressure - A report from SBU, the Swedish council on technology assessment in health care | 1995 | 0 | 65 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OPHTHALMOL NEPHROL | 1 | 50% | 0.7% | 1 |
2 | HLTH SCI AMARILLO | 0 | 10% | 0.7% | 1 |
3 | BISPEBJERG HOSP MED C T | 0 | 100% | 0.7% | 1 |
4 | CVD PREVENT | 0 | 100% | 0.7% | 1 |
5 | EXPLORAT FONCT ENDOCRINIENNES METAB | 0 | 100% | 0.7% | 1 |
6 | LADOKE AKINTOLA UNIV | 0 | 100% | 0.7% | 1 |
7 | MED C PROSPECT MED SECT | 0 | 100% | 0.7% | 1 |
8 | OSPED R SILVESTRINI S ANDREA FRATTE | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000146786 | INTEGRATED CARDIOVASC CLIN NETWORK SA//PREVENTAT HLTH//ANGIOTENSIN CONVERTING ENZYME INHIBITOR THERAPY |
2 | 0.0000133029 | SEROTONINERGIC AGONISTS//STRAITUM//NUCLEI RAPHE |
3 | 0.0000098371 | DOXAZOSIN//AJ 2615//MONATEPIL MALEATE |
4 | 0.0000083599 | MED PL PHYSIOL//BAP METABOLITES//KIDNEY NEOPLASMS THERAPY |
5 | 0.0000079676 | REDUCTIVE RING CLOSURE//THERMAL CYCLISATION//PHENOXYBENZAMINE HYDROCHLORIDE |
6 | 0.0000077441 | APPOINTMENT NON ATTENDANCE//EBELTOFT HLTH PROMOT STUDY//MULTIPHASIC SCREENING |
7 | 0.0000073696 | EDTA CHELATION//DIPARTIMENTO MORFOL UMANA SCI BIOMED CITTA//SURROGATE CRITERIA |
8 | 0.0000069294 | MRC TRIAL//ABORAT PREVENT TREATMENT CARDIOVASC DIS//CLIN EPIDEMIOL HLTH CARE PROGRAM MED |
9 | 0.0000067958 | RADIATION DANGER//NAVY DIVERS//BASIC CONVICTIONS |
10 | 0.0000065972 | PULSE PRESSURE//PSEUDOHYPERTENSION//PENAZ METHOD |